Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
August 23, 2017
Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD<sup>+</sup>) synthetase inhibitors as potential antitubercular agents
Xu Wang, Yong-Mo Ahn, Adam G Lentscher, et al.
Plos One
|
October 19, 2012
Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy
Elizabeth S McKenney, Michelle Sargent, Hameed Khan, et al.
Journal of Medicinal Chemistry
|
February 13, 2009
Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles
Pilho Kim, Liang Zhang, Ujjini H Manjunatha, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 3, 2006
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
Ujjini H Manjunatha, Helena Boshoff, Cynthia S Dowd, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 24, 2013
The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs
Emily R Jackson, Géraldine San Jose, Robert C Brothers, et al.
Chemmedchem
|
August 4, 2016
Targeting an Aromatic Hotspot in Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase with β-Arylpropyl Analogues of Fosmidomycin
Sanjeewani Sooriyaarachchi, René Chofor, Martijn D P Risseeuw, et al.
Medchemcomm
|
August 6, 2013
Design of Potential Bisubstrate Inhibitors against <i>Mycobacterium tuberculosis</i> (Mtb) 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (Dxr)-Evidence of a Novel Binding Mode
Géraldine San Jose, Emily R Jackson, Eugene Uh, et al.
RSC Medicinal Chemistry
|
July 19, 2024
Inhibition of DXR in the MEP pathway with lipophilic <i>N</i>-alkoxyaryl FR900098 analogs
Darean Bague, Ruiqin Wang, Dana Hodge, et al.
Plos One
|
August 30, 2014
Kinetic characterization and allosteric inhibition of the Yersinia pestis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase)
Amanda Haymond, Chinchu Johny, Tyrone Dowdy, et al.
Analytical Biochemistry
|
November 29, 2017
A high-throughput screening campaign to identify inhibitors of DXP reductoisomerase (IspC) and MEP cytidylyltransferase (IspD)
Amanda Haymond, Tyrone Dowdy, Chinchu Johny, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry Letters
|
August 23, 2017
Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD<sup>+</sup>) synthetase inhibitors as potential antitubercular agents
Xu Wang, Yong-Mo Ahn, Adam G Lentscher, et al.
Plos One
|
October 19, 2012
Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy
Elizabeth S McKenney, Michelle Sargent, Hameed Khan, et al.
Journal of Medicinal Chemistry
|
February 13, 2009
Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles
Pilho Kim, Liang Zhang, Ujjini H Manjunatha, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 3, 2006
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
Ujjini H Manjunatha, Helena Boshoff, Cynthia S Dowd, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 24, 2013
The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs
Emily R Jackson, Géraldine San Jose, Robert C Brothers, et al.
Chemmedchem
|
August 4, 2016
Targeting an Aromatic Hotspot in Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase with β-Arylpropyl Analogues of Fosmidomycin
Sanjeewani Sooriyaarachchi, René Chofor, Martijn D P Risseeuw, et al.
Medchemcomm
|
August 6, 2013
Design of Potential Bisubstrate Inhibitors against <i>Mycobacterium tuberculosis</i> (Mtb) 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (Dxr)-Evidence of a Novel Binding Mode
Géraldine San Jose, Emily R Jackson, Eugene Uh, et al.
RSC Medicinal Chemistry
|
July 19, 2024
Inhibition of DXR in the MEP pathway with lipophilic <i>N</i>-alkoxyaryl FR900098 analogs
Darean Bague, Ruiqin Wang, Dana Hodge, et al.
Plos One
|
August 30, 2014
Kinetic characterization and allosteric inhibition of the Yersinia pestis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase)
Amanda Haymond, Chinchu Johny, Tyrone Dowdy, et al.
Analytical Biochemistry
|
November 29, 2017
A high-throughput screening campaign to identify inhibitors of DXP reductoisomerase (IspC) and MEP cytidylyltransferase (IspD)
Amanda Haymond, Tyrone Dowdy, Chinchu Johny, et al.
Page
of 5